Profil
Dr. Christine Yuan Huang is a scientific-physician and biotech entrepreneur.
She is dedicated to transitioning laboratory technologies to clinical applications to assist patients with serious illnesses.
She brings her specialized expertise to her role as an advisor at LongeVC.
Selected for Forbes China's "30 Under 30" in Healthcare and Science in 2020, Dr. Huang is a biomedicine investment consultant for China Internet Investment Finance Holding Limited.
She's a Fellow of The Royal Society of Medicine (UK) and is on the Advisory Board for Wing Wah Charity Foundation Hong Kong.
Dr. Huang is the Technology Transfer Director at Hong Kong Quantum AI Lab (the University of Hong Kong and California Institute of Technology joint R&D infrastructure), Managing Director of HK Longevity Medical Center, and Venture Partner at LongeVC.
She's also a Senior Research Associate at the University of Hong Kong and was recently elected as a Fellow of the Guangzhou Youth Federation in 2022.
Dr. Huang graduated from Southern Medical University with degrees in Medicine and Science.
She later earned a Master's degree from the Li Ka Shing Faculty of Medicine at the University of Hong Kong and trained in Neurology at Queen Mary Hospital, Hong Kong.
Aktive Positionen von Christine Huang
Unternehmen | Position | Beginn |
---|---|---|
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | Berater | - |
Ehemalige bekannte Positionen von Christine Huang
Unternehmen | Position | Ende |
---|---|---|
CHINA CASTSON 81 FINANCE COMPANY LIMITED | Corporate Officer/Principal | 30.09.2023 |
Cellomics International Ltd.
Cellomics International Ltd. Miscellaneous Commercial ServicesCommercial Services Cellomics International Ltd. is a Chinese biotechnology company that focuses on developing and commercializing liquid biopsy products and services. The company is based in Hong Kong, Hong Kong. Cellomics International was founded by Christine Huang and Edwin Yu, with Christine Huang serving as the CEO since incorporation. | Geschäftsführer | 01.05.2022 |
City University of Hong Kong | Corporate Officer/Principal | 01.07.2020 |
Bacmuno Biotechnology Ltd.
Bacmuno Biotechnology Ltd. Pharmaceuticals: MajorHealth Technology Bacmuno Biotechnology Ltd. provides bacteria-based immunotherapies against cancer. It applies Salmonella genetic modification technology to cancer immunotherapy in animals and humans. The company was founded on January 23, 2017 and is headquartered in Hong Kong. | Gründer | 01.06.2019 |
Queen Mary Hospital
Queen Mary Hospital Hospital/Nursing ManagementHealth Services Queen Mary Hospital operates general medical hospitals. The private company is based in Hong Kong, Hong Kong. The CEO of the Chinese company is Yau Fun Lau. | Corporate Officer/Principal | 31.12.2017 |
Ausbildung von Christine Huang
University of Hong Kong | Graduate Degree |
Southern Medical University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CHINA CASTSON 81 FINANCE COMPANY LIMITED | Finance |
Private Unternehmen | 4 |
---|---|
Queen Mary Hospital
Queen Mary Hospital Hospital/Nursing ManagementHealth Services Queen Mary Hospital operates general medical hospitals. The private company is based in Hong Kong, Hong Kong. The CEO of the Chinese company is Yau Fun Lau. | Health Services |
Bacmuno Biotechnology Ltd.
Bacmuno Biotechnology Ltd. Pharmaceuticals: MajorHealth Technology Bacmuno Biotechnology Ltd. provides bacteria-based immunotherapies against cancer. It applies Salmonella genetic modification technology to cancer immunotherapy in animals and humans. The company was founded on January 23, 2017 and is headquartered in Hong Kong. | Health Technology |
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | Finance |
Cellomics International Ltd.
Cellomics International Ltd. Miscellaneous Commercial ServicesCommercial Services Cellomics International Ltd. is a Chinese biotechnology company that focuses on developing and commercializing liquid biopsy products and services. The company is based in Hong Kong, Hong Kong. Cellomics International was founded by Christine Huang and Edwin Yu, with Christine Huang serving as the CEO since incorporation. | Commercial Services |